AGP Executive Report
Last update: 11 hours agoDrug Patent Dispute: A Dutch court has blocked the manufacture, sale and storage of injectable Keytruda in the Netherlands and seven other European countries, siding with Halozyme in a patent case. MSD says it is reviewing its options. Prostate Care: An international study that included patients in the Netherlands found AI-assisted MRI assessment could help clinicians avoid some unnecessary prostate biopsies, which can be invasive. Medicine Supply Chains: Schiphol has joined Pharma.Aero, a global network working to strengthen pharmaceutical logistics and healthcare supply chains. Hepatitis Testing: The Dutch Health Institute is calling for more testing to help reduce hepatitis B and C infections.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.